Companies & Industry »Company News»Company News Details
Company News Details

BSE   08 Feb 16 | 12:00 AM

327.40 0.6 (0.18%)
Mkt Price (Rs)   Chg Rs (Chg %)
Code: 532321
Face Value: N.A.

NSE   08 Feb 16 | 12:00 AM

327.10 0.65 (0.2%)
Mkt Price (Rs)   Chg Rs (Chg %)
Code: CADILAHC
Performance
1 Week : Rs 318.80 (2.70%)
1 Month : Rs 310.10 (5.58%)
1 Year : Rs 292.83 (11.81%)
change companytradenow
Back

Cadila's stock rising: Credit Suisse

Reuters / 18 Jul 12 | 11:50 AM

Credit Suisse initiates coverage on Cadila Healthcare with an "outperform" rating and a target price of Rs 970.

Investment bank says the midcap drug maker has demonstrated "strong execution" in the United States, with a portfolio mix focusing on low competition products such as nasal sprays and injectable drugs.

USFDA approval of its facilities in Moraiya, part of Gujarat, will re-start new approvals of its drugs in the US market, Credit Suisse adds.

"Cadila is moving up the value-chain with the launch of difficult-to formulate products and its strong execution record provides multi-year growth visibility."

Sensex

Company Price Gain (%)
Axis Bank408.402.38
St Bk of India172.052.29
Bharti Airtel311.001.27
Lupin1,818.900.97
GAIL (India)343.500.59

Online Portfolio

You can create Online Portfolio here using the below button.